1.11
+0.217(+24.30%)
Currency In USD
| Previous Close | 0.89 |
| Open | 1.09 |
| Day High | 1.47 |
| Day Low | 1.05 |
| 52-Week High | 6.89 |
| 52-Week Low | 0.56 |
| Volume | 61.42M |
| Average Volume | 1.01M |
| Market Cap | 18.35M |
| PE | -0.63 |
| EPS | -1.75 |
| Moving Average 50 Days | 0.82 |
| Moving Average 200 Days | 1.81 |
| Change | 0.22 |
If you invested $1000 in iBio, Inc. (IBIO) 10 years ago, it would be worth $0.33 as of October 21, 2025 at a share price of $1.11. Whereas If you bought $1000 worth of iBio, Inc. (IBIO) shares 5 years ago, it would be worth $1.17 as of October 21, 2025 at a share price of $1.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025
GlobeNewswire Inc.
11 hours ago
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at iBio, will deliver an oral prese
iBio Announces Closing of $50 Million Public Offering
GlobeNewswire Inc.
Aug 25, 2025 11:00 AM GMT
Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant Asset Management, Adage Capital Partners LP, Ally Brid
iBio Announces Pricing of $50 Million Public Offering
GlobeNewswire Inc.
Aug 19, 2025 12:01 PM GMT
SAN DIEGO, Aug. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering (the “offering”) of (i) pre-funded warrants to purchase 7